ArticleJHEP reports : innovation in hepatology2026
Plasma GPC3 reflects tumor GPC3 expression and predicts clinical outcomes in advanced HCC treated with atezolizumab + bevacizumab.
Dong Jun Shin et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.